Learn how GLP‑1/GIP dual agonists like tirzepatide work at the molecular level to enhance insulin secretion, improve glucose control, and drive greater weight loss than GLP‑1 drugs alone. Explore mechanisms, incretin hormones, and key clinical trial results.
Discover how tirzepatide’s dual GIP and GLP‑1 receptor agonism sets it apart from traditional GLP‑1 drugs like semaglutide. Learn about its unique mechanism of action, powerful HbA1c reductions, double‑digit weight loss, and broad cardiometabolic benefits in type 2 diabetes and obesity.